| (Values in U.S. Thousands) | Mar, 2026 | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 |
| Sales | 16,000 | 13,790 | 12,060 | 9,640 | 7,650 |
| Sales Growth | +16.03% | +14.34% | +25.10% | +26.01% | +126.33% |
| Net Income | -2,400 | -8,420 | -14,090 | -18,660 | -29,130 |
| Net Income Growth | +71.50% | +40.24% | +24.49% | +35.94% | -88.06% |
Biotricity Inc (BTCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada.
Fiscal Year End Date: 03/31